Hidden depression in otolaryngology patients with medically unexplained symptoms
Hidden depression in otolaryngology patients with medically unexplained symptoms
复制标题
DOI：
10.1016/j.genhosppsych.2011.09.014
复制
发表时间：
2012-03-01
影响因子：
7
通讯作者：
Mimura, Masaru
中科院分区：
文献类型：
--
作者：
Goto, Fumiyuki;Tsutsumi, Tomoko;Mimura, Masaru
目的：探讨耳鼻喉科患者中抑郁症的患病率与医学原因不明的症状（MUS）和治疗的结果与选择性5-羟色胺再摄取抑制剂（SSRIs）。方法：90例MUS患者的人口983连续耳鼻喉科门诊入选。抑郁自评量表（SDS）用于筛查抑郁。除标准治疗外，所有抑郁症和非抑郁症患者均接受8周SSRIs治疗。采用临床总体印象改善量表（CGI-I）评价MUS患者的临床变化。抑郁症的患者表现出更好的结果比那些没有抑郁症，表现出更显着改善CGI-I scores.Conclusion：超过一半的人与耳鼻喉科MUS抑郁症，和他们的MUS成功地治疗SSRIs。(C)2012 Elsevier Inc. All rights reserved.
Objective: To investigate the prevalence of depression among otolaryngology patients with medically unexplained symptoms (MUS) and the outcome of treatment with selective serotonin reuptake inhibitors (SSRIs).Method: Ninety patients with MUS from a population of 983 consecutive otolaryngology outpatients were enrolled. The Self-Rating Depression Scale (SDS) was used to screen for depression. In addition to standard treatment, all depressed and nondepressed patients received SSRIs for 8 weeks. The Clinical Global Impression-Improvement (CGI-I) scale was used to evaluate clinical changes in patients with MUS.Results: There were 49 patients with depression among those with MUS, according to the SDS criteria. The patients with depression showed a better outcome than those without depression, demonstrating more significantly improved CGI-I scores.Conclusion: More than half of the individuals with otolaryngological MUS had depression, and their MUS were successfully treated with SSRIs. (C) 2012 Elsevier Inc. All rights reserved.